Amarantus BioSciences, Inc. Provides Update on #C4CT Concussion Awareness Summit on June 21 in Minneapolis
5/6/2013 6:49:11 AM
More...
|
Amarantus BioSciences, Inc. Posts LymPro Test® Alzheimer's Diagnostic White Paper to Web Site
4/25/2013 1:26:07 PM
More...
|
Reminder: Amarantus BioSciences, Inc. Business Update Conference Call Today at 4:30 p.m. Eastern
4/16/2013 6:53:27 AM
More...
|
Amarantus BioSciences, Inc. to Present at Biotechnology Industry Organization (BIO) Business Forum April 23rd
4/15/2013 6:48:56 AM
More...
|
Amarantus BioSciences, Inc. Announces Preclinical Development Timeline for MANF Therapeutic
4/11/2013 12:14:46 PM
More...
|
Amarantus BioSciences, Inc. Outlines LymPro Alzheimer's Diagnostic Development Strategy
4/8/2013 9:54:51 AM
More...
|
Amarantus BioSciences, Inc. Modifies Business Structure to Support Product Development Strategy
4/5/2013 9:51:57 AM
More...
|
Amarantus BioSciences, Inc. Appoints Adam J. Simon, Ph.D., to Board of Advisors
4/2/2013 6:31:25 AM
More...
|
Amarantus BioSciences, Inc. Reports Positive MANF Data in Neuroprotection Animal Models of Parkinson's Disease
3/27/2013 11:03:50 AM
More...
|
Amarantus BioSciences, Inc. Obtains Cessation of Unauthorized Listing on Berlin-Bremen Stock Exchange
3/20/2013 9:32:54 AM
More...
|
|